Primary peritoneal carcinoma Trials in Shanghai, China
Conditions / Primary peritoneal carcinoma / Shanghai, China
Primary peritoneal carcinoma has been the subject of sustained clinical investigation across multiple research sites.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02584478 | Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) | UNKNOWN | PHASE3 |
| NCT02859038 | Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04515602 | Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS) | NOT_YET_RECRUITING | PHASE3 |
| NCT05236686 | Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer | RECRUITING | NA |
| NCT03983226 | Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial) | RECRUITING | PHASE2 |
| NCT05200260 | Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer | RECRUITING | PHASE2 |
| NCT06602063 | Surgery for Relapsed Ovarian Cancer in Precision | NOT_YET_RECRUITING | PHASE1/PHASE2 |
| NCT05579366 | Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) | RECRUITING | PHASE1/PHASE2 |
| NCT02595021 | Total/Subtotal Colectomy in Ovarian Cancer | UNKNOWN | PHASE2 |
| NCT01669226 | First-line Intraperitoneal Cisplatin and Etoposide Chemotherapy for Ovarian Cancer | COMPLETED | PHASE2 |